评估贝叶斯剂量计算器的评估,用于增强脏清除率的儿科患者的万科米辛
Abdullah Alsultan1,2, Muneera Al-Jelaify3, Huda Alshahrani4
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Frontiers in pediatrics
|December 19, 2025
概括
在儿童中,脏清除 (ARC) 增加可能导致低范科米辛水平. 在使用测量药物水平时,NextDose计算器提高了万科米辛剂量准确性,特别是在ARC患者中.
科学领域:
- 药理动力学和药理动力学
- 儿科药理学 儿科药理学
- 药物剂量优化 药物剂量优化
背景情况:
- 增加脏清除 (ARC) 在儿科瘤学和ICU患者中很普遍.
- ARC可能会导致治疗次的万科米辛度,影响治疗的疗效.
- 个性化剂量至关重要,但贝叶斯工具在儿科ARC中的性能尚未得到充分研究.
研究的目的:
- 评估 NextDose 贝叶斯剂量计算器对儿科患者的万科米辛的预测准确度.
- 下一篇:在患有和没有增强干净度 (ARC) 的患者中比较剂量表现.
- 评估NextDose对优化儿童群体中万科米辛治疗的实用性.
主要方法:
- 对接受万科米的儿科患者 (1-12岁) 进行了回顾性观察研究.
- ARC定义为估计的膜过率 (eGFR) >130毫升/分钟/1.73米2.
- 评估先验 (临床数据) 和后期 (药物水平信息) 下一个使用rMPE和rMAPE的剂量预测.
主要成果:
- 在112名儿科患者中,有42%符合ARC标准.
- 先验预测显示高偏差 (rMPE 27%) 和中度精度 (rMAPE 31%).
- 后期预测的准确性明显提高 (rMPE -3.9%,rMAPE 13.5%),在ARC患者中表现优越 (rMAPE 12%与17.5%对比).
结论:
- 下一篇先验剂量范科米辛预测可能会高估度,限制初始剂量计算的实用性.
- 纳入测量中的万科米辛水平大大提高了NextDose的预测准确性,特别是在儿科ARC患者中.
- 下一剂量,结合治疗药物监测,有助于个性化范胺剂量在不同功能儿童.
相关概念视频
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
192
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
192
Drug Dosing: Infants and Children
231
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
170
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
170
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
215
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
215
Estimation of k and VD of Aminoglycosides
193
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
193


